Find similar products:
The text only version may be available in large print, Braille or audio CD.
For further information call emc accessibility on
0800 198 5000.
The product code(s) for this leaflet is: PL 16363/0641.
Apixaban Milpharm 5mg film-coated Tablets
Apixaban 5 mg film-coated tablets
apixaban
1. What Apixaban is and what it is used for
2. What you need to know before you take Apixaban
3. How to take Apixaban
4. Possible side effects
5. How to store Apixaban
6. Contents of the pack and other information
Apixaban contains the active substance apixaban and belongs to a group of medicines called anticoagulants. This medicine helps to prevent blood clots from forming by blocking Factor Xa, which is an important component of blood clotting.
Apixaban is used in adults:
Apixaban is used in children aged 28 days to less than 18 years to treat blood clots and to prevent re-occurrence of blood clots in the veins or in the blood vessels of the lungs.
For body weight appropriate recommended dose, see section 3.
Talk to your doctor, pharmacist or nurse before you take this medicine if you have any of the following:
Take special care with apixaban
If you need to have surgery or a procedure which may cause bleeding, your doctor might ask you to temporarily stop taking this medicine for a short while. If you are not sure whether a procedure may cause bleeding ask your doctor.
This medicine is not recommended in children and adolescents with a body weight of less than 35 kg.
Tell your doctor, pharmacist or nurse if you are taking, have recently taken or might take any other medicines.
Some medicines may increase the effects of Apixaban and some may decrease its effects. Your doctor will decide, if you should be treated with Apixaban when taking these medicines and how closely you should be monitored.
The following medicines may increase the effects of Apixaban and increase the chance for unwanted bleeding:
The following medicines may reduce the ability of Apixaban to help prevent blood clots from forming:
If you are pregnant or breast-feeding, think you may be pregnant or are planning to have a baby, ask your doctor, pharmacist or nurse for advice before taking this medicine.
The effects of Apixaban on pregnancy and the unborn child are not known. You should not take this medicine if you are pregnant.
Contact your doctor immediately if you become pregnant while taking Apixaban.
It is not known if Apixaban passes into human breast milk. Ask your doctor, pharmacist or nurse for advice before taking this medicine while breast-feeding. They will advise you whether to stop breast-feeding or to stop/not start taking Apixaban.
Apixaban has not been shown to impair your ability to drive or use machines.
If you have been told by your doctor that you have an intolerance to some sugars, contact your doctor before taking this medicinal product.
Apixaban contains less than 1 mmol (23 mg) of sodium per film coated tablet, that is to say it is essentially ‘sodium-free.’
Always take this medicine exactly as your doctor or pharmacist has told you. Check with your doctor, pharmacist or nurse if you are not sure.
Swallow the tablet with a drink of water. Apixaban can be taken with or without food.
Try to take the tablets at the same times every day to have the best treatment effect.
If you have difficulty swallowing the tablet whole, talk to your doctor about other ways to take Apixaban. The tablet may be crushed and mixed with water, or 5% glucose in water, or apple juice or apple puree, immediately before you take it.
If necessary, your doctor may also give you the crushed Apixaban tablet mixed in 60 mL of water or 5% glucose in water, through a nasogastric tube.
To prevent a blood clot from forming in the heart in patients with an irregular heart beat and at least one additional risk factor.
The recommended dose is one tablet of Apixaban 5 mg twice a day.
The recommended dose is one tablet of Apixaban 2.5 mg twice a day if:
The recommended dose is one tablet twice a day, for example, one in the morning and one in the evening. Your doctor will decide how long you must continue treatment for.
To treat blood clots in the veins of your legs and blood clots in the blood vessels of your lungs
The recommended dose is two tablets of Apixaban 5 mg twice a day for the first 7 days, for example, two in the morning and two in the evening.
After 7 days the recommended dose is one tablet of Apixaban 5 mg twice a day, for example, one in the morning and one in the evening.
For preventing blood clots from re-occurring following completion of 6 months of treatment
The recommended dose is one tablet of Apixaban 2.5 mg twice a day for example, one in the morning and one in the evening.
Your doctor will decide how long you must continue treatment for.
Use in children and adolescents
For treating blood clots and to prevent re-occurrence of blood clots in the veins or in the blood vessels of your lungs.
Always take or give this medicine exactly as your or the child’s doctor or pharmacist has told you. Check with your or the child’s doctor, pharmacist or nurse if you are not sure.
Try to take or give the dose at the same time every day to have the best treatment effect.
The dose of Apixaban depends on the body weight, and will be calculated by the doctor.
The recommended dose for children and adolescents weighing at least 35 kg is two tablets of Apixaban 5 mg twice a day for the first 7 days, for example, two in the morning and two in the evening.
After 7 days the recommended dose is one tablet of Apixaban 5 mg twice a day, for example, one in the morning and one in the evening.
For parents or caregivers: please observe the child to ensure that the full dose is taken.
It is important to keep scheduled doctor’s visits because the dose may need to be adjusted as the weight changes.
Your doctor might change your anticoagulant treatment as follows:
If your abnormal heartbeat needs to be restored to normal by a procedure called cardioversion, take this medicine at the times your doctor tells you, to prevent blood clots in blood vessels in your brain and other blood vessels in your body.
Tell your doctor immediately if you have taken more than the prescribed dose of Apixaban. Take the medicine pack with you, even if there are no tablets left.
If you take more Apixaban than recommended, you may have an increased risk of bleeding. If bleeding occurs, surgery, blood transfusions or other treatments that may reverse anti-factor Xa activity may be required.
If you are not sure what to do or have missed more than one dose, ask your doctor, pharmacist or nurse.
Do not stop taking Apixaban without talking to your doctor first, because the risk of developing a blood clot could be higher if you stop treatment too early.
If you have any further questions on the use of this medicine, ask your doctor, pharmacist or nurse.
Like all medicines, this medicine can cause side effects, although not everybody gets them. The most common general side effect of this medicine is bleeding which may be potentially life threatening and require immediate medical attention.
The following side effects are known if you take Apixaban to prevent blood clots from forming in the heart in patients with an irregular heart beat and at least one additional risk factor.
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Very rare side effects (may affect up to 1 in 10,000 people)
Not known (frequency cannot be estimated from the available data)
The following side effects are known if you take Apixaban to treat or prevent re-occurrence of blood clots in the veins of your legs and blood clots in the blood vessels of your lungs.
Common side effects (may affect up to 1 in 10 people)
Uncommon side effects (may affect up to 1 in 100 people)
Rare side effects (may affect up to 1 in 1,000 people)
Bleeding:
Not known (frequency cannot be estimated from the available data)
Additional side effects in children and adolescents
Tell the child’s doctor immediately if you observe any of these symptoms;
In general, the side effects observed in children and adolescents treated with Apixaban were similar in type to those observed in adults were primarily mild to moderate in severity. Side effects that were observed more often in children and adolescents were nose bleed and abnormal vaginal bleeding.
Very Common side effects (may affect more than 1 in 10 people)
Bleeding including:
Common side effects (may affect up to 1 in 10 people)
Bleeding including:
Not known (frequency cannot be estimated from the available data)
Bleeding:
If you get any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this leaflet. You can also report side effects directly via Yellow Card Scheme Website: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store. By reporting side effects you can help provide more information on the safety of this medicine.
Keep this medicine out of the sight and reach of children.
Do not use this medicine after the expiry date which is stated on the blister and carton after EXP. The expiry date refers to the last day of that month.
This medicine does not require any special storage conditions
Do not throw away any medicines via wastewater or household waste. Ask your pharmacist how to throw away medicines you no longer use. These measures will help protect the environment.
The active substance is Apixaban. Each film-coated tablets contains 5 mg of apixaban
The other ingredients are:
Tablet core: Lactose, cellulose, microcrystalline (grade-101), sodium laurilsulfate, croscarmellose sodium, magnesium stearate.
Film coating:
Hypromellose 2910 (6 cps), triacetin, titanium dioxide, yellow iron oxide, red iron oxide.
Film-coated tablet.
Light pink to pink, oval, biconvex film-coated tablet, debossed with ‘N’ on one side and ‘5’ on the other side.
Apixaban film-coated tablets are available in blister packs.
Pack sizes:
Blister Packs: 10, 20, 28, 56 & 60 film-coated tablets.
Not all pack sizes may be marketed
Inside the Apixaban pack together with the package leaflet you will find a Patient Alert Card or your doctor might give you a similar card.
This Patient Alert Card includes information that will be helpful to you and alert other doctors that you are taking Apixaban. You should keep this card with you at all times.
1. Take the card
2. Separate the language as needed (this is facilitated by the perforated edges)
3. Complete the following sections or ask your doctor to do it:
4. Fold the card and keep it with you at all times
or
or
This leaflet was last revised in 10/2024.